Q BioMed Inc (QBIO) Stock Price & News - Google Finance (2024)

Markets

US

Europe

Asia

Currencies

Crypto

Futures

DAX18,557.27-0.51%-95.40DAX18,557.270.51%
FTSE 1008,245.37-0.48%-39.97FTSE 1008,245.370.48%
CAC 408,001.80-0.48%-38.32CAC 408,001.800.48%
IBEX 3511,404.90-0.34%-39.10IBEX 3511,404.900.34%
STOXX 505,051.31-0.35%-17.78STOXX 505,051.310.35%

HomeQBIO • OTCMKTS

Q BioMed Inc

$0.00010

Pre-market:

$0.00

(99.00%)-0.000099

Closed: Jun 7, 4:55:18 PM GMT-4 · USD · OTCMKTS · Disclaimer

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Navidea Biopharmaceuticals Inc

$0.000010

NAVB90.00%

Evelo Biosciences Inc

$0.00060

EVLO0.00%

Nymox Pharmaceutical Corp

$0.19

NYMXF11.44%

Aridis Pharmaceuticals Inc

$0.070

ARDS7.69%

Ampio Pharmaceuticals Inc

$0.13

AMPE0.00%

Endonovo Therapeutics Inc

$0.0010

ENDV9.09%

Propanc Biopharma Inc

$0.0017

PPCB31.25%

ProtoKinetix, Inc.

$0.015

PKTX0.27%

Emmaus Life Sciences Inc

$0.092

EMMA0.00%

Respirerx Pharmaceuticals Inc

$0.0020

RSPI4.76%

Market news

CRWD2.53%

Crowdstrike Holdings Inc

.INX0.11%

S&P 500

GDDY0.50%

Godaddy Inc

Financials

Income Statement

Revenue

Net income

(USD)Feb 2023info

Fiscal Q1 2023 ended 2/28/23.

Y/Y change

Revenue

The total amount of income generated by the sale of goods or services related to the company's primary operations

Operating expense

Represents the total incurred expenses through normal operations

442.51K

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-721.61K

Net profit margin

Measures how much net income or profit is generated as a percentage of revenue.

Earnings per share

Represents the company's profit divided by the outstanding shares of its common stock.

EBITDA

Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances

-432.51K

Effective tax rate

The percent of their income that a corporation pays in taxes

Total assets

Total liabilities

(USD)Feb 2023info

Fiscal Q1 2023 ended 2/28/23.

Y/Y change

Cash and short-term investments

Investments that are relatively liquid and have maturities between 3 months and one year

23.17K

Total assets

The total amount of assets owned by a company

3.46M

Total liabilities

Sum of the combined debts a company owes

9.91M

Total equity

The value of subtracting the total liabilities from the total assets of a company

-6.44M

Shares outstanding

Total number of common shares outstanding as of the latest date disclosed in a financial filing

145.09M

Price to book

A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock

-0.00

Return on assets

A financial ratio that shows a company’s profitability compared to its assets

-31.88%

Return on capital

Company’s return above the average cost it pays for its debt and equity capital

77.66%

Net change in cash

(USD)Feb 2023info

Fiscal Q1 2023 ended 2/28/23.

Y/Y change

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-721.61K

Cash from operations

Net cash used or generated for core business activities

-138.19K

Cash from investing

Net cash used or generated in investing activities such as purchasing assets

Cash from financing

Net cash used or generated in financing activities such as dividend payments and loans

111.39K

Net change in cash

The amount by which a company's cash balance increases or decreases in an accounting period

-294.04K

Free cash flow

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments

1.58M

Stock

Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned

US listed security

Listed on OTCMKTS

Previous close

The last closing price

$0.00

Day range

The range between the high and low prices over the past day

$0.00010 - $0.00010

Market cap

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

150.00 USD

Avg Volume

The average number of shares traded each day over the past 30 days

9.25K

P/E ratio

The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks

-

Dividend yield

The ratio of annual dividend to current share price that estimates the dividend return of a stock

-

Primary exchange

Listed exchange for this security

OTCMKTS

About

Founded

2013

Employees

2

Discover more

You may be interested in

info

This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

IndexDow Jones Industrial Average38,798.990.22%
ISPIntesa Sanpaolo SpA€3.590.39%
AMZNAmazon.com Inc$184.300.38%
IndexEURO STOXX 505,051.310.35%
TSLATesla Inc$177.480.26%
IndexDAX PERFORMANCE-INDEX18,557.270.51%
IndexNasdaq-10019,000.950.11%
AAPLApple Inc$196.891.24%
UCGUniCredit SpA€36.570.19%
IndexNasdaq Composite17,133.120.23%
IndexVIX12.222.86%
IndexFTSE 100 Index8,245.370.48%
ENIEni SpA€13.990.55%
LDOLeonardo SpA€24.171.81%
ENELEnel S.p.A. Ordinary Shares€6.711.29%
GAssicurazioni Generali SpA€23.790.63%
IndexSTOXX Europe 600523.550.22%

People also search for

NAVBNavidea Biopharmaceuticals Inc$0.00001090.00%
EVLOEvelo Biosciences Inc$0.000600.00%
NYMXFNymox Pharmaceutical Corp$0.1911.44%
ARDSAridis Pharmaceuticals Inc$0.0707.69%
AMPEAmpio Pharmaceuticals Inc$0.130.00%
ENDVEndonovo Therapeutics Inc$0.00109.09%
PPCBPropanc Biopharma Inc$0.001731.25%
PKTXProtoKinetix, Inc.$0.0150.27%
EMMAEmmaus Life Sciences Inc$0.0920.00%
RSPIRespirerx Pharmaceuticals Inc$0.00204.76%
CPMDCannapharmarx Inc$0.01612.14%
PHGEBiomx Inc$0.355.24%
CVSICV Sciences Inc$0.0895.94%
IPCIFIntellipharmaceutics International Inc$0.100.00%
ELOXEloxx Pharmaceuticals Inc$0.697.36%
QLGNQualigen Therapeutics Inc$0.209.09%
BLONFCO2 GRO Inc$0.0433.89%
ARECAmerican Resources Corp$1.150.00%

Q BioMed Inc (QBIO) Stock Price & News - Google Finance (7)HelpSend feedbackPrivacyTermsDisclaimer

Q BioMed Inc (QBIO) Stock Price & News - Google Finance (2024)
Top Articles
Latest Posts
Article information

Author: Lidia Grady

Last Updated:

Views: 5886

Rating: 4.4 / 5 (65 voted)

Reviews: 80% of readers found this page helpful

Author information

Name: Lidia Grady

Birthday: 1992-01-22

Address: Suite 493 356 Dale Fall, New Wanda, RI 52485

Phone: +29914464387516

Job: Customer Engineer

Hobby: Cryptography, Writing, Dowsing, Stand-up comedy, Calligraphy, Web surfing, Ghost hunting

Introduction: My name is Lidia Grady, I am a thankful, fine, glamorous, lucky, lively, pleasant, shiny person who loves writing and wants to share my knowledge and understanding with you.